SCOTT M NEVILLE
- Type
- Physician · Podiatric Medicine & Surgery Service Providers / Podiatrist / Foot & Ankle Surgery
- Where
- MOORESVILLE, IN
- NPI
- 1457319253
- Received
- $352,899 in 507 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 79 | $40,627 |
| 2024 | General payment | 61 | $34,220 |
| 2023 | General payment | 68 | $52,965 |
| 2022 | General payment | 70 | $58,183 |
| 2021 | General payment | 77 | $52,519 |
| 2020 | General payment | 43 | $40,231 |
| 2019 | General payment | 109 | $74,153 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Horizon Therapeutics plc | 297 | $243,849 | 2019–2023 |
| Amgen Inc. | 106 | $73,982 | 2022–2025 |
| Integra LifeSciences Corporation | 52 | $32,796 | 2019–2022 |
| Nvision Biomedical Technologies, Inc. | 2 | $999 | 2021 |
| Kerecis Limited | 9 | $249 | 2023–2025 |
| Stryker Corporation | 7 | $247 | 2019–2025 |
| ANI Pharmaceuticals, Inc. | 9 | $225 | 2023–2025 |
| DePuy Synthes Sales Inc. | 3 | $121 | 2025 |
| MIMEDX Group, Inc. | 1 | $51 | 2025 |
| Medtronic, Inc. | 2 | $44 | 2024–2025 |
| Orthofix Medical, Inc. | 3 | $42 | 2022–2025 |
| Averitas Pharma Inc. | 2 | $41 | 2023–2025 |
| Zimmer Biomet Holdings, Inc. | 2 | $37 | 2020–2021 |
| Smith+Nephew, Inc. | 2 | $35 | 2019–2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $30 | 2025 |
| Abbott Laboratories | 1 | $24 | 2024 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 | 2025 |
| Reprise Biomedical, Inc. | 1 | $18 | 2025 |
| Organogenesis Inc. | 1 | $18 | 2022 |
| PolyNovo North America LLC | 1 | $17 | 2024 |
| TREACE MEDICAL CONCEPTS, INC. | 1 | $16 | 2025 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 | 2024 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Honoraria | 85 | $193,654 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 43 | $79,864 |
| Travel and Lodging | 194 | $61,222 |
| Consulting Fee | 4 | $9,668 |
| Food and Beverage | 180 | $8,484 |
| Education | 1 | $5 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Amgen Inc. | $10 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-20 | ANI Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-30 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-28 | ANI Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-27 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-07 | DePuy Synthes Sales Inc. | $37 | Food and Beverage | In-kind items and services | MOTOBAND Device, Trauma | 2025 | |
| 2025-09-30 | VERTEX PHARMACEUTICALS INCORPORATED | $14 | Food and Beverage | In-kind items and services | JOURNAVX Drug, PAIN | 2025 | |
| 2025-09-25 | Amgen Inc. | $9 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-20 | Orthofix Medical, Inc. | $4 | Food and Beverage | Cash or cash equivalent | Physio-Stim Device, Stimulator, Bone Growth, Non-Invasive | 2025 | |
| 2025-09-17 | MIMEDX Group, Inc. | $51 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-11 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-09 | ANI Pharmaceuticals, Inc. | $30 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-08-20 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-18 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-18 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-15 | Amgen Inc. | $46 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-12 | ANI Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-08-05 | ANI Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-08-04 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-04 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-01 | Amgen Inc. | $47 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-07-29 | Amgen Inc. | $121 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-23 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-16 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-12 | Paratek Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | NUZYRA Drug, ANTIBIOTIC | 2025 | |
| 2025-06-03 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-30 | Amgen Inc. | $179 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-28 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-28 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-27 | Orthofix Medical, Inc. | $19 | Food and Beverage | Cash or cash equivalent | Physio-Stim Device, Stimulator, Bone Growth, Non-Invasive | 2025 | |
| 2025-05-21 | Amgen Inc. | $294 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-21 | Amgen Inc. | $121 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-21 | Amgen Inc. | $75 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-21 | Amgen Inc. | $46 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-21 | Amgen Inc. | $38 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-20 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-20 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-15 | Medtronic, Inc. | $24 | Food and Beverage | In-kind items and services | VENASEAL Device, EndoVenous Therapies | 2025 | |
| 2025-05-02 | Amgen Inc. | $481 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-02 | Amgen Inc. | $108 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-02 | Amgen Inc. | $90 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-02 | Amgen Inc. | $46 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-29 | Averitas Pharma Inc. | $23 | Food and Beverage | In-kind items and services | QUTENZA Drug, PAIN MANAGEMENT | 2025 | |
| 2025-04-25 | Kerecis Limited | $5 | Food and Beverage | Cash or cash equivalent | Kerecis SurgiClose Device, Wound Care | 2025 | |
| 2025-04-22 | Reprise Biomedical, Inc. | $18 | Food and Beverage | In-kind items and services | Miro3D Device, Wound Dressing | 2025 | |
| 2025-04-09 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-09 | Amgen Inc. | $1,744 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-09 | Amgen Inc. | $961 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-08 | Amgen Inc. | $125 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-02 | Kerecis Limited | $4 | Food and Beverage | Cash or cash equivalent | Kerecis SurgiClose Device, Wound Care | 2025 | |
| 2025-04-01 | Stryker Corporation | $34 | Food and Beverage | In-kind items and services | ORTHOLOC 2 LAPIFUSE Device, TRAUMA & EXTREMITIES | 2025 | |
| 2025-03-27 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-27 | Amgen Inc. | $1,158 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-27 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-25 | Amgen Inc. | $549 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-25 | Amgen Inc. | $73 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-25 | Amgen Inc. | $28 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-25 | Amgen Inc. | $14 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-20 | VERTEX PHARMACEUTICALS INCORPORATED | $15 | Food and Beverage | In-kind items and services | JOURNAVX Drug, PAIN | 2025 | |
| 2025-03-19 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-13 | Amgen Inc. | $35 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-13 | Amgen Inc. | $25 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-13 | Amgen Inc. | $20 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-11 | DePuy Synthes Sales Inc. | $38 | Food and Beverage | In-kind items and services | MOTOBAND Device, Trauma | 2025 | |
| 2025-03-06 | Amgen Inc. | $306 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-04 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-04 | Amgen Inc. | $1,744 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-26 | DePuy Synthes Sales Inc. | $44 | Food and Beverage | In-kind items and services | MOTOBAND Device, Trauma | 2025 | |
| 2025-02-25 | TREACE MEDICAL CONCEPTS, INC. | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-19 | Amgen Inc. | $348 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-19 | Kerecis Limited | $7 | Food and Beverage | Cash or cash equivalent | Kerecis SurgiClose Device, Wound Care | 2025 | |
| 2025-02-18 | Amgen Inc. | $149 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-14 | Kerecis Limited | $5 | Food and Beverage | Cash or cash equivalent | Kerecis SurgiClose Device, Wound Care | 2025 | |
| 2025-02-13 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-13 | Amgen Inc. | $1,744 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-12 | Amgen Inc. | $483 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-07 | Amgen Inc. | $40 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-27 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-16 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2024-12-17 | Amgen Inc. | $127 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-12-17 | Amgen Inc. | $8 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-12-03 | Pacira Pharmaceuticals Incorporated | $15 | Food and Beverage | In-kind items and services | Exparel Drug, Pain Management | 2024 | |
| 2024-11-25 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-11-01 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-24 | Smith+Nephew, Inc. | $23 | Food and Beverage | In-kind items and services | GRAFIX PL Medical Supply, Other Advanced Wound Management | 2024 | |
| 2024-10-02 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-02 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-09-25 | Amgen Inc. | $124 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-09-23 | Abbott Laboratories | $24 | Food and Beverage | In-kind items and services | PROCLAIM Device, Neuromodulation | 2024 | |
| 2024-09-19 | PolyNovo North America LLC | $17 | Food and Beverage | In-kind items and services | NOVOSORB BTM Device, SYNTHETIC DERMAL SUBSTITUTE | 2024 | |
| 2024-09-06 | Medtronic, Inc. | $19 | Food and Beverage | In-kind items and services | INTELLIS ADAPTIVESTIM Device, Spinal Cord Neurostimulation | 2024 | |
| 2024-09-06 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-28 | Kerecis Limited | $46 | Food and Beverage (5 payments) | Cash or cash equivalent | Kerecis Omega3 SurgiClose Device, Wound Care | 2024 | |
| 2024-08-21 | Kerecis Limited | $88 | Food and Beverage (8 payments) | Cash or cash equivalent | Kerecis Omega3 SurgiClose Device, Wound Care | 2024 | |
| 2024-08-15 | ANI Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-08-08 | Kerecis Limited | $17 | Food and Beverage | Cash or cash equivalent | Kerecis Omega3 SurgiClose Device, Wound Care | 2024 | |
| 2024-08-03 | Amgen Inc. | $55 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-03 | Amgen Inc. | $45 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-03 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-03 | Amgen Inc. | $25 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-02 | Amgen Inc. | $282 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-02 | Amgen Inc. | $150 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-02 | Amgen Inc. | $62 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-02 | Amgen Inc. | $55 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-02 | Amgen Inc. | $51 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-08-02 | Amgen Inc. | $18 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-07-30 | Stryker Corporation | $47 | Food and Beverage | In-kind items and services | EASYFUSE Device, TRAUMA & EXTREMITIES | 2024 | |
| 2024-07-29 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-07-26 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-07-26 | Amgen Inc. | $1,744 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-07-19 | Amgen Inc. | $294 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-07-18 | Amgen Inc. | $513 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-21 | Amgen Inc. | $4,796 | Consulting Fee | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-21 | Amgen Inc. | $302 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-21 | Amgen Inc. | $34 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-21 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-21 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-20 | Amgen Inc. | $213 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-20 | Amgen Inc. | $125 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-13 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-12 | Amgen Inc. | $513 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-05 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-06-05 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-05-30 | Amgen Inc. | $2,616 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-05-30 | Amgen Inc. | $436 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-05-28 | Amgen Inc. | $282 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-05-28 | Amgen Inc. | $42 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-05-09 | ANI Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-05-01 | Amgen Inc. | $872 | Consulting Fee | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-04-17 | Kerecis Limited | $28 | Food and Beverage (2 payments) | Cash or cash equivalent | Kerecis Omega3 SurgiClose Device, Wound Care | 2024 | |
| 2024-03-04 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-02-08 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-02-02 | Amgen Inc. | $4,360 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-02-02 | Amgen Inc. | $991 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-02-02 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-02-01 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-01-25 | Amgen Inc. | $3,052 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-01-18 | Amgen Inc. | $125 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-01-08 | Amgen Inc. | $14 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-01-05 | Amgen Inc. | $9 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2023-12-20 | Horizon Therapeutics plc | $14 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-19 | Horizon Therapeutics plc | $1 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $4,360 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $2,616 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $1,094 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $192 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $145 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $130 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $7 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-12 | Horizon Therapeutics plc | $0 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-12-07 | ANI Pharmaceuticals, Inc. | $31 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | 2023 | |
| 2023-11-16 | Horizon Therapeutics plc | $2,180 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-11-07 | Horizon Therapeutics plc | $3,488 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-11-07 | Horizon Therapeutics plc | $1,323 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-11-07 | Horizon Therapeutics plc | $1,148 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-11-07 | Horizon Therapeutics plc | $54 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-11-03 | Horizon Therapeutics plc | $1,308 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-10-30 | Horizon Therapeutics plc | $3 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-28 | Kerecis Limited | $45 | Food and Beverage (3 payments) | Cash or cash equivalent | Kerecis Omega3 SurgiClose Device, Wound Care | 2023 | |
| 2023-09-28 | Horizon Therapeutics plc | $6 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-21 | Horizon Therapeutics plc | $4,360 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-21 | Horizon Therapeutics plc | $375 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-21 | Horizon Therapeutics plc | $264 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-21 | Horizon Therapeutics plc | $211 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-21 | Horizon Therapeutics plc | $31 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-09-14 | ANI Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | 2023 | |
| 2023-09-12 | Horizon Therapeutics plc | $5 | Education | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-29 | Horizon Therapeutics plc | $2,616 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-29 | Horizon Therapeutics plc | $124 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-29 | Horizon Therapeutics plc | $49 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-21 | Horizon Therapeutics plc | $27 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $4,578 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $373 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $299 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $149 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $85 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $84 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $64 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $34 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-05 | Horizon Therapeutics plc | $34 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-08-01 | Horizon Therapeutics plc | $3 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-07-24 | Horizon Therapeutics plc | $2,180 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-07-24 | Horizon Therapeutics plc | $34 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-07-13 | Horizon Therapeutics plc | $107 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-06-15 | Horizon Therapeutics plc | $11 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-06-15 | Horizon Therapeutics plc | $1 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-06-01 | Horizon Therapeutics plc | $5 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-05-03 | Horizon Therapeutics plc | $2,616 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-05-03 | Horizon Therapeutics plc | $48 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-28 | Averitas Pharma Inc. | $18 | Food and Beverage | In-kind items and services | QUTENZA Drug, PAIN MANAGEMENT | 2023 | |
| 2023-04-27 | Horizon Therapeutics plc | $13 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-20 | Horizon Therapeutics plc | $2,616 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-20 | Horizon Therapeutics plc | $1,209 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-18 | Horizon Therapeutics plc | $1,308 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-10 | Horizon Therapeutics plc | $872 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-10 | Horizon Therapeutics plc | $654 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-04-06 | Horizon Therapeutics plc | $3 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-03-29 | Horizon Therapeutics plc | $1,308 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-02-28 | Horizon Therapeutics plc | $4,360 | Honoraria | Cash or cash equivalent | KRYSTEXXA Biological, KRYSTEXXA | 2023 | |
| 2023-02-28 | Horizon Therapeutics plc | $890 | Travel and Lodging | In-kind items and services | KRYSTEXXA Biological, KRYSTEXXA | 2023 |
The latest 200 records of 507.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Mooresville, IN, county Morgan County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Mooresville, IN | County Morgan County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 9,751 | 72,659 | 6,851,073 |
| Population, 2020 census P1 | 9,411 | 71,780 | 6,785,528 |
| Median age B01002 | 40.7 | 41.7 | 38.1 |
| Under 18 B01001 | 21.1% | 22.1% | 23.3% |
| 65 and over B01001 | 23.0% | 18.1% | 16.8% |
| Households B11001 | 3,924 | 28,279 | 2,716,009 |
| Foreign born B05002 | 1.5% | 1.3% | 6.3% |
| Median household income B19013 | $68,983 | $79,429 | $71,957 |
| Median family income B19113 | $80,874 | $97,659 | $90,767 |
| Per capita income B19301 | $32,788 | $40,144 | $38,351 |
| Poverty rate B17001 | 13.0% | 9.3% | 12.3% |
| Unemployment rate B23025 | 3.4% | 4.2% | 4.3% |
| Civilian labor force B23025 | 4,513 | 36,026 | 3,472,016 |
| Mean commute (minutes) B08013 | 28.3 | 31.5 | 24.1 |
| Bachelor's degree or higher B15003 | 21.7% | 21.1% | 29.5% |
| Housing units B25001 | 4,181 | 30,046 | 2,976,568 |
| Owner-occupied B25003 | 67.9% | 82.1% | 70.6% |
| Renters B25003 | 32.1% | 17.9% | 29.4% |
| Median home value B25077 | $206,400 | $237,600 | $218,200 |
| Median gross rent B25064 | $1,089 | $1,042 | $1,062 |
| White, not Hispanic B03002 | 91.0% | 93.5% | 75.4% |
| Black B03002 | 1.8% | 0.8% | 9.1% |
| Hispanic or Latino B03002 | 3.3% | 2.1% | 8.6% |
| Asian B03002 | 0.3% | 0.5% | 2.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Mooresville, IN.
Comments